RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 34 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $695,859 | +84.5% | 91,380 | +58.9% | 0.02% | +88.9% |
| Q2 2023 | $377,200 | +152.3% | 57,500 | +130.0% | 0.01% | +125.0% |
| Q1 2023 | $149,500 | -8.3% | 25,000 | -64.3% | 0.00% | 0.0% |
| Q4 2022 | $163,100 | +8.0% | 70,000 | +55.6% | 0.00% | 0.0% |
| Q3 2022 | $151,000 | -18.8% | 45,000 | -35.7% | 0.00% | 0.0% |
| Q2 2022 | $186,000 | -36.7% | 70,000 | -30.0% | 0.00% | -33.3% |
| Q1 2022 | $294,000 | -65.6% | 100,000 | 0.0% | 0.01% | -62.5% |
| Q4 2021 | $855,000 | +14.8% | 100,000 | 0.0% | 0.02% | +14.3% |
| Q3 2021 | $745,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |